Hyelim Cho

Hyelim Cho

Company: Takeda Pharmaceuticals

Job title: Group Lead, Immunogenicity


Immunogenicity & Antigenicity-Based T-Cell & Epitopes Identification for Design of Biologic Therapeutics 10:00 am

In silico analysis as an integrative approach for the assessment of immunogenicity in the pre-clinical phase In vitro validation study to offer predictive insights on immunogenicity of biotherapeutics Remaining challenges to offer better predictive insights to mitigate clinical immunogenicity risk of biotherapeuticsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.